Crossref
Inhaled Epoprostenol for an Intermediate-High-Risk Pulmonary Embolism With an Aortic Intramural Hematoma
Annals of Internal Medicine: Clinical Cases · 01.08.2026 · 5 (8)
DOI: 10.7326/aimcc.2026.0148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Internal Medicine: Clinical Cases, erschienen am 01.08.2026. Verfasst von James E. Carlton und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Carlton, J. E., & Kovalenko, I. (2026). Inhaled Epoprostenol for an Intermediate-High-Risk Pulmonary Embolism With an Aortic Intramural Hematoma. Annals of Internal Medicine: Clinical Cases, 5(8). https://doi.org/10.7326/aimcc.2026.0148
Vancouver
Carlton JE, Kovalenko I. Inhaled Epoprostenol for an Intermediate-High-Risk Pulmonary Embolism With an Aortic Intramural Hematoma. Annals of Internal Medicine: Clinical Cases. 2026;5(8). doi:10.7326/aimcc.2026.0148
BibTeX
@article{Carlton2026,
author = {Carlton, James E. and Kovalenko, Iuliia},
title = {Inhaled Epoprostenol for an Intermediate-High-Risk Pulmonary Embolism With an Aortic Intramural Hematoma},
journal = {Annals of Internal Medicine: Clinical Cases},
year = {2026},
volume = {5},
number = {8},
doi = {10.7326/aimcc.2026.0148}
}
EUVIMED